±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1676  |  »Ø¸´: 27
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

cpucqzj

¶Ò»»¹ó±ö

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

[½»Á÷] ÓйؿµÄùµÒ¸ñÖÝ´óѧ²©ºóÉêÇëµÄÊÂÇéÇë½Ì£¡£¡50½ð±Ò·îËÍ£¡£¡

¸÷λ¶Ô¿µÄùµÒ¸ñ´óѧÁ˽âµÄ´óÏÀ£¬Çë°ïæ
Õ⼸ÌìÀϰå´òËã°ïÎÒÍÆ¼öµ½¿µÄùµÒ¸ñ´óѧ×ö²©ºó
µ«ÎÒ¶Ô¸ÃУÓÈÆäÊÇÄ¿±êµ¼Ê¦ÖªÖ®ÉõÉÙ£¬±Ï¾¹ÓÖÊÇÀϰå½éÉܵģ¬Èç¹ûóȻ´ðÓ¦Ï벻ȥ¾Í²»ºÃÁË£¬µ«Ò²²»ÄÜÍÏÌ«¾Ã£¬×ÜÒª¸øËû¸ö´ð¸´µÄ¡£
ÏȲ»Ëµ·Ï»°ÁË£¬°ÑÄ¿±êÀϰåÐÅÏ¢ÌùÉÏÀ´°É ´ó¼Ò°ïÎÒÄøöÖ÷Òâ
Diane J. Burgess
Ph.D.
Board of Trustees Distinguished Professor
Professor of Pharmaceutics
University of Connecticut
School of Pharmacy
ËäÈ»¾Ý˵·¢¹ý100ƪÒÔÉÏÎÄÕ£¬µ«´ó¶àÔÚ3-5·ÖÖ®¼ä£¬×î¸ßµÄ6.5£¬Ò²Óкܶà2·ÖÒÔϵģ¬Í·ÏκÃÏñͦ¶à£¬ÊÇÊ²Ã´ÌØÆ¸½ÌÊÚʲôЭ»áÖ÷ϯʲôҩµäίԱ»áÉúÎïÖÆÒ©ÆÀÉóר¼ÒµÈ£¬ÄùýÁ½´ÎУÓÅÐã½Ìʦ½±¡£ÎÒ×ܾõµÃËý²àÖØÓÚ½ÌѧºÍÐÐÕþ£¬Òª²»È»Ó¦¸ÃÓÐ10·ÖÒÔÉϵÄÎÄÕ³öÀ´µÄ¡£
ËýµÄ·½ÏòºÍÎҵĺÜÎǺϣ¬ÊÇ×ö¸ß·Ö×ÓÒ©ÎïÔØÌåµÄ£¬Ñо¿½çÃæ»¯Ñ§£¬Ò©Îï¿ØÊ͵ȣ¬Èç¹ûÈ¥ÁË£¬¾Í²»ÓÃΪ¹¤×÷ºÍ¸÷ÖÖÉêÇë·³ÐÄ£¬Ö»ÊÇÈ¥ÁËÈç¹ûûÓÐºÜºÃµÄÆ½Ì¨·¢µãÅ£µÄpaper£¬Ò²ÊDz»Ì«ÖµµÃµÄ¡£±¾ÈËÏÖÔÚÓÖÈýƪ3.0ÒÔÉÏÎÄÕ£¬journal of controlled release, nanotechnology, pharmaceutical research. ×ܾõµÃÎÒÔÚ¹úÄÚÒѾ­ÓÐ5·ÖµÄÎÄÕÂÁË£¬ÔÙµ½¹úÍâÐÁÐÁ¿à¿à»¹ÊǺÜÄÑ·¢7·ÖÒÔÉϵÄÎÄÕ£¬×ܾõµÃÓе㲻ÇéÔ¸£¬µ«ÊÇÕâ±Ï¾¹ÊÇ»ú»á£¬ÏÖÔÚ³ö¹úÒ²ÊǺܷ³¶øÇÒÒ²²»ÈÝÒ×ÕÒµ½Ì«Å£µÄʵÑéÊÒ¡£ÎҺܳÇë´ó¼Ò°ïæ¡£
£¨ÒÔÏÂÊÇËýµÄÏêϸÇé¿ö£¬ÇëÈÈÐÄ´óÏÀÂÔ¿´£¬Ð»Ð»£¡£¡£©

Diane J. Burgess
Ph.D.
Board of Trustees Distinguished Professor
Professor of Pharmaceutics

University of Connecticut
School of Pharmacy, Room 432
69 North Eagleville Road, Unit 3092
Storrs, Connecticut 06269-3092

Phone: (860) 486-3760
Fax: (860) 486-2076
E-Mail: d.burgess@uconn.edu

Educational Background
◊  Postdoctural Research, Universities of Amsterdam, Nottingham, and North Carolina   
◊ Ph.D., University of London, United Kingdom     
◊ B.Sc., University of Strathclyde, Glasgow, United Kingdom
     
Professional Accomplishments

Dr. Burgess was the recipient of the Outstanding Teacher of the Year Award (2005 and 1992).  She was the 2002 President of the American Association of Pharmaceutical Scientists (AAPS) and is an AAPS fellow.  She was recently elected Vice President of the Controlled Release Society and will be the 2009-2010 President.  She is currently a member of the USP Biopharmaceuticals Expert committee and is a member of the USP Advisory Panel on Injectables.  Dr. Burgess was an editor for AAPSharmsci (1999-2005) and is editor of the Journal of Drug Delivery Science and Technology (2003-present) and serves on the editorial boards of: the Journal of Pharmacy and pharmacology (1997-present); the Journal of Microencapsulationi (1997-present); Crital Reviewers in Therapeutic Drug Carrier Systems (2004-present); the International Journal of Pharmaceutics (2004-present); and the Journal of Diabetes Science and Technology (2006-present).  In 2001 she underook a sabbatical leave at the Office of Testing and Research at CDER, FDA.  She consults for pharmaceutical, food, cosmetic and other engineering industries on issues related to dispersed systems, in vitro release testing, IVIVC, interfacial chemistry and particle size analysis.

Professional Interests

Dr. Burgess runs a multidisciplinary laboratory.  Research efforts focus on drug delivery systems, in particular, nonoparticles, microspheres, emulsions, liposomes, hydrogels, and novel coatings for implantable devises as well as interfacial chemistry.  Research interests include small molecule drugs, proteins, peptides and DNA therapeutics.  Together with faculty in Chemistry (Dr. Fotios Papadimitrakopoulos) and Electrical Engineering (Dr. Faquir Jain), Dr. Burgess is developing a miniaturized, implantable biosensor for metabalic monitoring.  The team is developing an implantable coating to control tissue response to implantable devices.  Drs. Burgess and Papidimitrakopoulos are using quantum dots to investigate intracellular traficking of DNA therapeutics and vectors.  Dr. Burgess' group is developing in vitro performance tests for controlled release parenterals products and has collaborations with both the Food and Drug Association (FDA) and the United States Pharmacopeia (USP).  This work includes evaluation of in vitro and in vivo correlation (IVIVC) of controlled release parenterals and development of appropriate in vitro release testing methods.  Other important research areas are investigation of both nanoparticle and emulsion stability using a variety interfacial techniques and particle size analysis.

Selected Recent Publications (out of over 100 publications)  
1.  B.S. Zolnik, and D.J. Burgess*.  Evaluation of In vivo - In vitro Release of Dexamethasome from PLGA Microspheres. J. Controlled Release 2008 (127) 137-145.
   
2.  U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess*.  Controlling Acute Inflammation with fast-releasing dexamethasone PLGA microsphere/PVA hydrogel composites for implantable devices.  Journal of Diabetes Science and Technology 2007, 1(1) 8-17.
   
3.  S.D. Patil, F. Papidimitrakopoulos, and D.J. Burgess*.  Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J. Controlled Release 2007, 117(1) 68-79.
   
4.  C. Srinivasan, J. Lee, F. Papadimitrakopoulos, L.K. Silbart, M.H. Zhao and D.J. Burgess*.  Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots.  Molecular Therapy 2006, 14(2) 192-201.
   
5.  S.D. Patil, D.G. Rhodes, and D.J. Burgess*.  Bio-physical characterization of a novel anionic liposomal delivery system.  Biochimica et Biophysica Acta. 2005; 1711(1):1-11.
  Top ten most downloaded articles of 2005 in BBA.
   
6.  S.D. Patil, D.G. Rhodes and D.J. Burgess*.  DNA-based therapeutics and their delivery systems: A comprehensive review.  The AAPS J. 2005;7(1):article 9.
  2007 Outstanding Manuscript Award, The AAPS Journal
   
7.  S.D. Patil, D.G. Rhodes and D.J. Burgess*.  Anionic liposomal delivery system for DNA transfection.  The AAPS J. 2004:6(4);article 29.
   
8.  J. Jiao and D.J. Burgess*.  Ostwald ripening of water-in-hydrocarbon emulsions.  J. Coll. Interface Sci. 2003;264(2):506-516.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

kuaileren

°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-26 23:34
°ïÄã¶¥Ò»ÏÂ
¡°ÄãÒª¼áÐÅ£¬È˺£Ä°Éú£¬ÖʵØÎÂů¡£Ö»ÒªÄãÄܹ»ÓëÈËΪÁÚ¡¢ÓëÈ˹²Î裬Éç»áÉϾÍÓÐÐíÐí¶à¶àµÄÈÈÐÄÈ˵ÈÄã½áʶ¡¢µÈÄãºÏ×÷¡±¡£
2Â¥2009-10-26 22:48:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

arcwdf

³¬¼¶°æÖ÷

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-27 10:47
°ï¶¥Ò»ÏÂ
3Â¥2009-10-27 08:44:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

bobynana

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-27 10:47
ÕâÄêÍ·ÓÐÌÀºÈ¾Í²»´íÁË£¬»¹Ïë³ÔÈ⣬ÄѰ¡¡£¡£¡£
¸Ð¾õ»¹ÊÇ¿ÉÒÔµÄÁË£¬¿ÉÒÔÏÈ¿¼ÂÇ¿¼ÂÇÀ²
µÃɪ¸öɶ°¡£¡
4Â¥2009-10-27 09:26:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

P2K

³¬¼¶°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï ¡ï
cpucqzj(½ð±Ò+2,VIP+0):л뱦¹óÒâ¼û 10-27 10:48
È¥ÄÇÀï²»¹âÊÇ·¢ÎÄÕ£¬¸üÖØÒªµÄÊÇ»ýÀÛÈËÂö£¬Èç¹ûÄÜͨ¹ýÕâ¸öÀϰåÈÏʶºÜ¶àѧÊõȦÀïµÄÈË»òÕßÄܶÔÄãÆäËü·½ÃæÓкܴó°ïÖú£¬Ò²ºÜ²»´í
5Â¥2009-10-27 09:31:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ls407

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-28 08:11
¿ÉÒÔÏÈ¿¼ÂÇ¿¼ÂÇÀ²
6Â¥2009-10-27 15:10:28
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nano1

°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-28 08:12
¸Ð¾õ»¹ÊÇ¿ÉÒÔµÄÁË£¬¿ÉÒÔÏÈ¿¼ÂÇ¿¼ÂÇÀ²
7Â¥2009-10-27 15:21:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gaoming6232

ר¼Ò¹ËÎÊ

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0): 10-28 08:12
²»ÖªµÀÔõô˵.×Ô¼ºÏëÔõÑù¾ÍÔõÑù°É
ǧÈËÎÒËùÓûÒ²£¬Ç§ÈËÇàÄêÒàÎÒËùÓûÒ²£¬Á½Õß²»¿É¼æµÃ£¬Ç§ÈËÇàÄêÏȰÉ!
8Â¥2009-10-27 15:22:56
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

shenchunhui

ʵϰ°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï ¡ï
cpucqzj(½ð±Ò+2,VIP+0):лл¹ÄÀø£¡ 10-30 21:25
Õâ¸ö·½ÏòÕæ²»´í£¬ºÜºÃÕÒµ¥Î»¡£
9Â¥2009-10-30 03:27:45
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nosun

ʵϰ°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
cpucqzj(½ð±Ò+1,VIP+0):¹þ¹þ ¶Ô£¬×Ô¼ºµÄÊÂ×Ô¼º¶¨ 10-30 21:26
²»ÖªµÀÔõô˵.×Ô¼ºÏëÔõÑù¾ÍÔõÑù°É
10Â¥2009-10-30 08:05:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ cpucqzj µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 294·Ö080500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +12 ÁøÏª±ß 2026-03-26 13/650 2026-04-01 01:37 by 1018329917
[¿¼ÑÐ] 080200ѧ˶£¬»úе¹¤³Ìרҵ277·Ö£¬Çó´ø×ߣ¡ +4 Æ¿×ÓPZ 2026-03-31 4/200 2026-03-31 20:16 by vgtyfty
[¿¼ÑÐ] ÒѾö¶¨µ÷¼ÁԺУ +8 JKSOIID 2026-03-26 8/400 2026-03-31 19:51 by mg1014
[¿¼ÑÐ] ʡ˫һÁ÷ÖØµãÒ»±¾´óѧÕÐÊÕµ÷¼Á +3 wwwwffffff 2026-03-31 5/250 2026-03-31 19:49 by ÔøÔøÔø£¡
[¿¼ÑÐ] 375Çóµ÷¼Á +7 ÓêÏÄÕûÒ¹ 2026-03-29 7/350 2026-03-31 18:52 by xhai2011
[¿¼ÑÐ] »úеѧ˶×Ü·Ö317Çóµ÷¼Á£¡£¡£¡£¡ +6 Acaciad 2026-03-25 6/300 2026-03-31 16:52 by asdfzly
[¿¼ÑÐ] 08¹¤¿Æ£¬295£¬½ÓÊÜ¿çרҵµ÷¼Á +4 lmnlzy 2026-03-31 4/200 2026-03-31 15:25 by Î÷¾©Ñ§ÔºÕаì
[¿¼ÑÐ] 266·Ö£¬Çó²ÄÁÏÒ±½ðÄÜÔ´»¯¹¤µÈµ÷¼Á +8 ÍÛºôºßºôºß 2026-03-27 10/500 2026-03-31 13:35 by Huaxue_Wang
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйú¿ÆÑ§Ôº´óѧ265Çóµ÷¼Á +6 Ìñµ­ye 2026-03-31 7/350 2026-03-31 11:28 by Ìñµ­ye
[¿¼ÑÐ] Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ£¬»úе¹¤³Ìѧ˶£¬341 +3 Î÷¹ÏÌïµÄÊØÍûÕß 2026-03-30 3/150 2026-03-31 11:08 by asdfzly
[¿¼ÑÐ] 0856µ÷¼Á +6 ÇúÌýóÞ 2026-03-30 6/300 2026-03-31 09:44 by Jaylen.
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤µ÷¼ÁÒ»Ö¾Ô¸´óÁ¬º£ÊÂ085600£¬349 +6 ³ÔµÄ²»ÉÙ 2026-03-30 6/300 2026-03-31 04:17 by fmesaito
[¿¼ÑÐ] 285Çóµ÷¼Á +6 AZMK 2026-03-29 9/450 2026-03-30 21:02 by dophin1985
[¿¼ÑÐ] 342Çóµ÷¼Á +4 ¼ÓÓÍaÀîzs 2026-03-26 4/200 2026-03-30 16:39 by ¾§ÌåÖ®ÃÀ
[˶²©¼ÒÔ°] ÕÐÊÕÉúÎïѧ/ϸ°ûÉúÎïѧµ÷¼Á +4 IceGuo 2026-03-26 5/250 2026-03-29 01:25 by griffith2014
[¿¼ÑÐ] Çóµ÷¼Á +7 ÕùÈ¡¾Åµã˯ 2026-03-28 8/400 2026-03-28 21:07 by ÕùÈ¡¾Åµã˯
[¿¼ÑÐ] 085701»·¾³¹¤³Ì£¬267Çóµ÷¼Á +16 minht 2026-03-26 16/800 2026-03-28 12:16 by zllcz
[¿¼ÑÐ] 081200-314 +3 LILIQQ 2026-03-27 4/200 2026-03-28 09:41 by ±£»¤µØÇòÄãÎÒ×öÆ
[¿¼ÑÐ] 331»·¾³¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +3 ìÚÈ»ºÃÔËÆø 2026-03-27 3/150 2026-03-28 04:11 by fmesaito
[¿¼ÑÐ] Çóµ÷¼Á +3 ÀîÀî²»·þÊä 2026-03-25 3/150 2026-03-25 13:03 by cmz0325
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û